Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Tóm tắt
Từ khóa
Tài liệu tham khảo
Letterio, J. L. & Roberts, A. B. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137–161 (1998).
Czarnieki, C. W., Chiu, H. H., Wong, C. H., McCabe, S. M. & Palladino, M. A. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140, 4217–4223 (1988).
Bauvois, B., Rouillard, D., Sanceau, J. & Wietzerbin, J. IFN-γ and transforming growth factor-β1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J. Immunol. 148, 3912–3919 (1992).
Schmitt, E. et al. Thelper type I development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24, 793–798 (1994).
Xiao, B. G., Zhang, G. X., Ma, C. G. & Link, H. Transforming growth factor-β1 (TGF-β1)-mediated inhibition of glial cell proliferation and down-regulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-γ (IFN-γ). Clin. Exp. Immunol. 103, 475–481 (1996).
Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264 (1998).
Heldin, C.-H., Miyazono, K. & ten Dijke, P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465–471 (1997).
Schindler, C. & Darnell, J. E. Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64, 621–651 (1995).
Hayashi, H. et al. The MAD-related protein Smad7 associated with the TGFβ receptor and functions as an antagonist of TGFβ signalling. Cell 89, 1165–1173 (1997).
Nakao, A. et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389, 631–635 (1997).
Muller, M. et al. The protein tyrosine kinase Jak1 complements defects in interferon-α/β and -γ signal transduction. Nature 366, 129–135 (1993).
Cácamo, J. et al. Type I receptors specify growth inhibitory and transcriptional responses to TGF-β and activin. Mol. Cell Biol. 14, 3810–3821 (1994).
Chen, X., Rubock, M. J. & Whitman, M. Atranscriptional partner of MAD proteins in TGF-β signalling. Nature 383, 691–696 (1996).
Liu, F., Pouponnot, C. & Massagué, J. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional responses. Genes Dev. 11, 3157–3167 (1997).
Kretzschmar, M., Doody, J. & Massagué, J. Opposing BMP and EGF signalling pathway converge on the TGFβ family mediator Smad1. Nature 389, 618–622 (1997).
Sakatsume, M. et al. Interferon γ activation of Raf-1 is Jak1-dependent and p21ras-independent. J. Biol. Chem. 273, 3021–3026 (1998).
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. & Saltiel, A. R. Asynthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA 92, 7686–7689 (1995).
Muller, M. et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of the ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12, 4221–4228 (1993).
Spittler, A. et al. Effects of 1 α,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cells differentiation, activation and phagocytosis. Immunology 90, 286–293 (1997).
Lee, K., Tanaka, M., Hatanaka, M. & Kuze, F. Reciprocal effects of epidermal growth factor and transforming growth factor and transforming growth factor β on the anchorage-dependent and -independent growth of A431 epidermoid carcinoma cells. Exp. Cell Res. 173, 156–162 (1987).
Kumar, R. & Mendelsohn, J. Growth regulation of A431 cells. Modulation of expression of transforming growth factor-α mRNA and 2′,5′-oligoadenylate synthetase activity. J. Biol. Chem. 265, 4578–4582 (1990).
Souchelnytskyi, S. et al. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors. J. Biol. Chem. 273, 25364–25370 (1998).
Ohta, M., Greenberger, J. S., Anklesaria, P., Bassols, A. & Massagué, J. Two forms of transforming growth factor-β distinguished by multipotential hematopoietic progenitor cells. Nature 329, 539–541 (1987).
Zhang, Y., Feng, X.-H., Wu, R.-Y. & Derynck, R. Receptor-associated Mad homologues synergize as efectors of the TGFβ response. Nature 383, 168–172 (1996).
Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832–836 (1996).
Tu, G. C., Cao, Q.-N., Zhou, F. & Israel, Y. Tetranucleotide GGGA motif in primary RNA transcripts. Novel target for antisense design. J. Biol. Chem. 273, 25125–25131 (1998).
Hata, A., Lagna, G., Massagué, J. & Hemmati-Brivanlou, A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186–197 (1998).